Cambridge Innovation Capital
Paris, France
Cambridge Innovation Capital backs world-leading life sciences and technology companies with an affiliation to Cambridge, Europe’s leading capital for innovation. As a preferred investor for the University of Cambridge, we have unparalleled access to investment opportunities in the ecosystem. Since our inception in 2013, we have raised £275million to invest in disruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health and genomics/proteomics.
Founded:2013
Firm Location:Paris, France • London • Cambridge, United Kingdom
Investor Firms That Co-Invest with Cambridge Innovation Capital
Cambridge Innovation Capital Team
Investors in Cambridge (United Kingdom)
Investors in Cambridge (United Kingdom)
Investors in Cambridge (United Kingdom)
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in Diagnostics, Investors in Diagnostics, Investors in Digital Health, Investors in Digital Health, Investors in FinTech, Investors in FinTech, Investors in IoT, Investors in IoT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
Investors in Cambridge (United Kingdom)
Christopher Tapper
Sweet spot: $3.3M
Range: $600K - $6.0M
Investors in Cambridge (MA)
Investors in Cambridge (United Kingdom)
Investors in AI, Investors in AI, Investors in BioTech, Investors in BioTech, Investors in DeepTech, Investors in DeepTech, Investors in FinTech, Investors in FinTech, Investors in Material Science, Investors in Material Science